Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Dopamine D1 receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Serotonin 2a (5-HT2a) receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Dopamine D2 receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0024 | 0.0809 | 0.5 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0024 | 0.0809 | 0.0626 |
Giardia lamblia | Hypothetical protein | 0.0021 | 0.0626 | 0.5 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0024 | 0.0809 | 0.0809 |
Loa Loa (eye worm) | hypothetical protein | 0.0159 | 1 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0012 | 0 | 0.5 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0024 | 0.0809 | 0.5 |
Brugia malayi | flavodoxin family protein | 0.0024 | 0.0809 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0024 | 0.0809 | 0.5 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0024 | 0.0809 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0159 | 1 | 1 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0012 | 0.0012 | 0.0012 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0024 | 0.0809 | 0.5 |
Plasmodium vivax | unspecified product | 0.0101 | 0.6049 | 0.9176 |
Echinococcus multilocularis | serotonin receptor | 0.0159 | 1 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0012 | 0 | 0.5 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0024 | 0.0809 | 0.5 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0024 | 0.0809 | 1 |
Chlamydia trachomatis | sulfite reductase | 0.0015 | 0.0195 | 0.5 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0024 | 0.0809 | 0.5 |
Echinococcus multilocularis | serotonin receptor | 0.0159 | 1 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0024 | 0.0809 | 0.0626 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0159 | 1 | 1 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0024 | 0.0809 | 0.0626 |
Plasmodium vivax | unspecified product | 0.0108 | 0.6536 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0015 | 0.0195 | 0.0195 |
Leishmania major | p450 reductase, putative | 0.0024 | 0.0809 | 1 |
Trypanosoma cruzi | p450 reductase, putative | 0.0024 | 0.0809 | 0.5 |
Plasmodium falciparum | cysteine proteinase falcipain 1 | 0.0108 | 0.6536 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0024 | 0.0809 | 0.5 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0024 | 0.0809 | 0.0626 |
Brugia malayi | FAD binding domain containing protein | 0.0024 | 0.0809 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0024 | 0.0809 | 0.5 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0024 | 0.0809 | 0.0626 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0021 | 0.0626 | 0.5 |
Plasmodium vivax | vivapain-1 | 0.0108 | 0.6536 | 1 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0024 | 0.0809 | 0.0309 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0809 | 0.0626 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | Displacement of [3H]mesulergine from Sprague-Dawley rat brain cortex serotonin 5-HT2C receptor after 15 mins by liquid scintillation counting in presence of 5-HT2A blocker, spiperone | ChEMBL. | 22133459 | |
Ki (binding) | = 17.2 nM | Displacement of [3H]-8-OH-DPAT from Sprague-Dawley rat brain cortex serotonin 5-HT1A receptor after 30 mins by liquid scintillation counting | ChEMBL. | 22133459 |
Ki (binding) | = 52.4 nM | Displacement of [3H]SCH-23390 from rat corpora striatum dopamine D1 receptor after 15 mins by liquid scintillation counting | ChEMBL. | 22133459 |
Ki (binding) | = 2730 nM | Displacement of [3H]ketanserin from Sprague-Dawley rat brain cortex serotonin 5-HT2A receptor after 15 mins by liquid scintillation counting | ChEMBL. | 22133459 |
Ki (binding) | > 10000 nM | Displacement of [3H]spiperone from rat corpora striatum dopamine D2 receptor after 15 mins by liquid scintillation counting | ChEMBL. | 22133459 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.